Replies to post #136799 on PharmaCyte Biotech Inc (PMCB)

[DragonBear]

Your average biotech isn’t trying to treat late stage cancer

Neither was PMCB in the PR pump, involving Medpace. Do you remember:

“In this trial, we are hopeful that we won’t experience too much of that. The trial is designed for patients with locally advanced non-metastatic unresectable pancreatic cancer. Many patients with pancreatic cancer do have metastatic disease, meaning the spread of the cancer elsewhere in the body, not just a locally advanced disease. This therapy won’t offer a benefit to those patients and is designed for the non-metastatic locally advanced patient. We need to find locally advanced patients without metastases

Now considering 80% when diagnosed have metastasis. And having failed 1st line therapy are guaranteed of having detectable metastasis... GL in trying to find a late stage cancer patient without metastasis.

It's already accepted in the science community even early Stage 1 patients without detectable metastasis, have "micro-metastasis". Which manifests itself as 1st line starts to fail. Remove the primary tumor in a 1st line patient, and the cancer still comes back, due to the prior "micro-metastasis".

As for the claim the ave biotech isn't trying to treat late stage cancer, there are plenty out there in the Clintrial database.

[concordia]

An ordinary biotech. LOL you are correct PMCB is not an ordinary Biotech in fact they are not a real Biotech at all.

They’re attempting something amazing here. Ya Sucking tens of Millions from shareholders and accomplishing nothing while still having a job is amazing.